Table 1.
Studies reporting anti-D efficacy in adults and children including patients with newly diagnosed ITP
AEs indicates adverse events; and SAEs, significant adverse events.
*Classified by standard terminology at the time of publication; acute ITP < 6 months in duration.
†Chronic ITP > 6 months in duration.
